thecompanyoverview
Company Overview


HµREL® Corporation (“Hurel”) is a privately held bioanalytic tools company with corporate headquarters in Beverly Hills, California and laboratories situated in North Brunswick, New Jersey, USA. Robert Freedman is Hurel’s CEO.


HµRELToxTM
multi-readout, repeat-dose
DILI screening
DILI screening

Hurel microlivers afford better prediction than 3D

Toxicology Research
HµRELviralTM
Long-enduring infectious liver disease platform
Time-Based
Toxicity Ratios*
A new marker for hepatotoxic chronicity

TAAP
*patent pending
HµRELfluxTM
a new, patent-pending
efflux transport
assay method
DMPK
Superior intrinsic clearance
and biotransformation of
low-turnover drugs

DMD